This second episode in the series discusses the activities of the External Education FAWG and the different learning opportunities that are currently available and coming soon to all MAPS members.
This article provides top-level framework and broad conceptual categories for understanding digital structures within Medical Affairs and biopharmaceutical/MedTech organizations, helping leaders to make organizational decisions to drive their digital strategy with intention and purpose.
In this our third episode this season, we’ll be discussing how and why medical publishing is changing and where is it going in the future.
With a multibillion dollar investment from Microsoft and already 4 authorship credits on PubMed, ChatGPT is poised to disrupt Medical Affairs.
This webinar highlights the continued importance of omnichannel engagement for healthcare practitioners and learners and the need to equip our internal teams appropriately.
This series of the Elevate Podcast illuminates the path scientific communication takes from teaching to diagnosis to treating all the way to changing, prolonging, and saving patient lives.
From space biology to patient voice to best practices for onboarding, here are highlights of the APPA/MAPS Joint Medical Affairs Summit in Sydney, Australia.
At the MAPS 2022 Global Annual Meeting in New Orleans, we sat down with Medical Affairs leaders in attendance to discuss a range of issues important to the function. Now as we prepare for the MAPS 2023 Global Annual Meeting in Nashville, March 26-29 (early bird registration open until December 31!), join us in looking back at these important opinions. Have a topic you’d like covered at the 2023 meeting? Email MAPS Communications/Marketing Director, Garth Sundem, with your suggestions!
Based on discussions between 80 cross-industry Field Medical colleagues from small to large biopharmaceutical and medtech companies, this article highlights key actions for Medical Affairs teams to consider for implementation in their own organizations.
In this our second episode this season, we’ll be discussing open access in medical publishing from the biopharma perspective.